In contrast with IL6 and COL7A1, the lower expression of COL4A4 was often correlated with a lower clinical stage, pathological stage, and WHO grade, indicating COL4A4 is a protecting factor, while IL6 and COL7A1 are risk factors of ccRCC. This evidence concerns the gene COL4A4 and nonpapillary renal cell carcinoma.